M4MM

Gelato Cannabis Unifies Multi-State Structure

SAN DIEGO – Gelato Cannabis announced that it has completed the acquisition of its California operations, integrating them under a single ownership and leadership framework that now spans California, Michigan, and Arizona. The move brings ...

Clearmind Featured in Bipartisan Veterans Therapy Bill

WASHINGTON D.C. – The recent introduction of bipartisan legislation in the U.S. House of Representatives has drawn attention to Clearmind Medicine Inc.'s proprietary compound MEAI as part of efforts to broaden veterans' access to certain ...

Gelato Cannabis Unifies Multi-State Structure

SAN DIEGO – Gelato Cannabis announced that it has completed the acquisition of its California operations, integrating them under a single ownership and leadership framework that now spans California, Michigan, and Arizona. The move brings ...

Clearmind Featured in Bipartisan Veterans Therapy Bill

WASHINGTON D.C. – The recent introduction of bipartisan legislation in the U.S. House of Representatives has drawn attention to Clearmind Medicine Inc.'s proprietary compound MEAI as part of efforts to broaden veterans' access to certain ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...

California Allocates $30M in Cannabis Research Grants

SACRAMENTO – California's Department of Cannabis Control has disbursed nearly $30 million to support 22 academic projects examining Cannabis's influence on public health, environmental practices, and the regulated market. The funding, drawn from taxes on ...

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

Subscribe To Our Newsletter